134 related articles for article (PubMed ID: 37795907)
21. Expert pathology review and endoscopic mucosal resection alters the diagnosis of patients referred to undergo therapy for Barrett's esophagus.
Ayers K; Shi C; Washington K; Yachimski P
Surg Endosc; 2013 Aug; 27(8):2836-40. PubMed ID: 23389078
[TBL] [Abstract][Full Text] [Related]
22. Detection and staging of esophageal cancers within Barrett's esophagus is improved by assessment in specialized Barrett's units.
Cameron GR; Jayasekera CS; Williams R; Macrae FA; Desmond PV; Taylor AC
Gastrointest Endosc; 2014 Dec; 80(6):971-83.e1. PubMed ID: 24929493
[TBL] [Abstract][Full Text] [Related]
23. Risk of neoplastic progression in Barrett's esophagus diagnosed as indefinite for dysplasia: a nationwide cohort study.
Kestens C; Leenders M; Offerhaus GJ; van Baal JW; Siersema PD
Endoscopy; 2015 May; 47(5):409-14. PubMed ID: 25521571
[TBL] [Abstract][Full Text] [Related]
24. Extending treatment criteria for Barrett's neoplasia: results of a nationwide cohort of 138 endoscopic submucosal dissection procedures.
van Munster SN; Verheij EPD; Nieuwenhuis EA; Offerhaus JGJA; Meijer SL; Brosens LAA; Weusten BLAM; Alkhalaf A; Schenk EBE; Schoon EJ; Curvers WL; van Tilburg L; van de Ven SEM; Tang TJ; Nagengast WB; Houben MHMG; Seldenrijk KCA; Bergman JJGHM; Koch AD; Pouw RE;
Endoscopy; 2022 Jun; 54(6):531-541. PubMed ID: 34592769
[TBL] [Abstract][Full Text] [Related]
25. Association between length of Barrett's esophagus and risk of high-grade dysplasia or adenocarcinoma in patients without dysplasia.
Anaparthy R; Gaddam S; Kanakadandi V; Alsop BR; Gupta N; Higbee AD; Wani SB; Singh M; Rastogi A; Bansal A; Cash BD; Young PE; Lieberman DA; Falk GW; Vargo JJ; Thota P; Sampliner RE; Sharma P
Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1430-6. PubMed ID: 23707463
[TBL] [Abstract][Full Text] [Related]
26. Endoscopic submucosal dissection vs. endoscopic mucosal resection for early Barrett's neoplasia in the West: a retrospective study.
Mejia Perez LK; Yang D; Draganov PV; Jawaid S; Chak A; Dumot J; Alaber O; Vargo JJ; Jang S; Mehta N; Fukami N; Chua T; Gabr M; Kudaravalli P; Aihara H; Maluf-Filho F; Ngamruengphong S; Pourmousavi Khoshknab M; Bhatt A
Endoscopy; 2022 May; 54(5):439-446. PubMed ID: 34450667
[TBL] [Abstract][Full Text] [Related]
27. Management of low-grade dysplasia in Barrett's esophagus.
Wani S
Curr Opin Gastroenterol; 2012 Jul; 28(4):370-6. PubMed ID: 22508323
[TBL] [Abstract][Full Text] [Related]
28. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I
Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
[TBL] [Abstract][Full Text] [Related]
29. Endoscopic resection of Barrett's adenocarcinoma: Intramucosal and low-risk tumours are not associated with lymph node metastases.
Benech N; O'Brien JM; Barret M; Jacques J; Rahmi G; Perrod G; Hervieu V; Jaouen A; Charissoux A; Guillaud O; Legros R; Walter T; Saurin JC; Rivory J; Prat F; Lépilliez V; Ponchon T; Pioche M
United European Gastroenterol J; 2021 Apr; 9(3):362-369. PubMed ID: 32903167
[TBL] [Abstract][Full Text] [Related]
30. Barrett's Esophagus after Bimodality Therapy in Patients with Esophageal Adenocarcinoma.
Amlashi FG; Wang X; Davila RE; Maru DM; Bhutani MS; Lee JH; Weston BR; Mizrak Kaya D; Vassilakopoulou M; Harada K; Blum Murphy MA; Rice DC; Hofstetter WL; Davila M; Nguyen QN; Ajani JA
Oncology; 2018; 95(2):81-90. PubMed ID: 29843157
[TBL] [Abstract][Full Text] [Related]
31. Patients with nondysplastic Barrett's esophagus have low risks for developing dysplasia or esophageal adenocarcinoma.
Wani S; Falk G; Hall M; Gaddam S; Wang A; Gupta N; Singh M; Singh V; Chuang KY; Boolchand V; Gavini H; Kuczynski J; Sud P; Reddymasu S; Bansal A; Rastogi A; Mathur SC; Young P; Cash B; Lieberman DA; Sampliner RE; Sharma P
Clin Gastroenterol Hepatol; 2011 Mar; 9(3):220-7; quiz e26. PubMed ID: 21115133
[TBL] [Abstract][Full Text] [Related]
32. Incidence and Prediction of Unrelated Mortality After Successful Endoscopic Eradication Therapy for Barrett's Neoplasia.
van Munster SN; Verheij EPD; Ozdemir Ö; Toes-Zoutendijk E; Lansdorp-Vogelaar I; Nieuwenhuis EA; Cotton CC; Weusten BLAM; Alvarez Herrero L; Alkhalaf A; Schenk BE; Schoon EJ; Curvers WL; Koch AD; de Jonge PF; Tang TJ; Nagengast WB; Westerhof J; Houben MHMG; Shaheen NJ; Bergman JJGHM; Pouw RE
Gastroenterology; 2024 Jun; 166(6):1058-1068. PubMed ID: 38447738
[TBL] [Abstract][Full Text] [Related]
33. The Annual Risk of Esophageal Adenocarcinoma Does Not Decrease Over Time in Patients With Barrett's Esophagus.
Nguyen T; Thrift AP; Yu X; Duan Z; El-Serag HB
Am J Gastroenterol; 2017 Jul; 112(7):1049-1055. PubMed ID: 28244499
[TBL] [Abstract][Full Text] [Related]
34. Increasing prevalence of high-grade dysplasia and adenocarcinoma on index endoscopy in Barrett's esophagus over the past 2 decades: data from a multicenter U.S. consortium.
Desai M; Lieberman DA; Kennedy KF; Hamade N; Thota P; Parasa S; Gorrepati VS; Bansal A; Gupta N; Gaddam S; Young PE; Mathur S; Moawad FJ; Cash BD; Sampliner R; Vargo JJ; Falk GW; Sharma P
Gastrointest Endosc; 2019 Feb; 89(2):257-263.e3. PubMed ID: 30342028
[TBL] [Abstract][Full Text] [Related]
35. A randomised trial of endoscopic submucosal dissection versus endoscopic mucosal resection for early Barrett's neoplasia.
Terheggen G; Horn EM; Vieth M; Gabbert H; Enderle M; Neugebauer A; Schumacher B; Neuhaus H
Gut; 2017 May; 66(5):783-793. PubMed ID: 26801885
[TBL] [Abstract][Full Text] [Related]
36. Correlation between endoscopic forceps biopsies and endoscopic mucosal resection with endoscopic ultrasound in patients with Barrett's esophagus with high-grade dysplasia and early cancer.
Thota PN; Sada A; Sanaka MR; Jang S; Lopez R; Goldblum JR; Liu X; Dumot JA; Vargo J; Zuccarro G
Surg Endosc; 2017 Mar; 31(3):1336-1341. PubMed ID: 27444824
[TBL] [Abstract][Full Text] [Related]
37. Development and Validation of a Model to Determine Risk of Progression of Barrett's Esophagus to Neoplasia.
Parasa S; Vennalaganti S; Gaddam S; Vennalaganti P; Young P; Gupta N; Thota P; Cash B; Mathur S; Sampliner R; Moawad F; Lieberman D; Bansal A; Kennedy KF; Vargo J; Falk G; Spaander M; Bruno M; Sharma P
Gastroenterology; 2018 Apr; 154(5):1282-1289.e2. PubMed ID: 29273452
[TBL] [Abstract][Full Text] [Related]
38. Barrett's Registry Collaboration of academic centers in Ireland reveals high progression rate of low-grade dysplasia and low risk from nondysplastic Barrett's esophagus: report of the RIBBON network.
O'Byrne LM; Witherspoon J; Verhage RJJ; O'Brien M; Muldoon C; Ryan C; Buckley M; Murphy T; Reynolds R; Patchett S; Kay E; Azam H; Robb W; Arumugasamy M; Mathuna PM; Leyden J; Gargan S; Doherty G; Sheahan K; Collins C; Nath A; O'Sullivan J; Donohoe CL; Ravi N; O'Toole D; Reynolds JV
Dis Esophagus; 2020 Oct; 33(10):. PubMed ID: 32193532
[TBL] [Abstract][Full Text] [Related]
39. Multifocal neoplasia and nodal metastases in T1 esophageal carcinoma: implications for endoscopic treatment.
Altorki NK; Lee PC; Liss Y; Meherally D; Korst RJ; Christos P; Mazumdar M; Port JL
Ann Surg; 2008 Mar; 247(3):434-9. PubMed ID: 18376186
[TBL] [Abstract][Full Text] [Related]
40. Risk factors for progression of low-grade dysplasia in patients with Barrett's esophagus.
Wani S; Falk GW; Post J; Yerian L; Hall M; Wang A; Gupta N; Gaddam S; Singh M; Singh V; Chuang KY; Boolchand V; Gavini H; Kuczynski J; Sud P; Bansal A; Rastogi A; Mathur SC; Young P; Cash B; Goldblum J; Lieberman DA; Sampliner RE; Sharma P
Gastroenterology; 2011 Oct; 141(4):1179-86, 1186.e1. PubMed ID: 21723218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
